These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 4384083)

  • 1. [Deadyn: treatment of behavior disorders].
    Dall'Oglio GN
    Riv Sper Freniatr Med Leg Alien Ment; 1967 Apr; 91(2):576-82. PubMed ID: 4384083
    [No Abstract]   [Full Text] [Related]  

  • 2. [New orientation in the pharmacological management of mental retardation].
    De Cándenas V
    Rev Clin Esp; 1969 Jan; 112(2):183-92. PubMed ID: 4388803
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical evaluation of pemoline and magnesium hydroxide as a mild stimulant in geriatric patients.
    Goldstein BJ; Braunstein J
    Curr Ther Res Clin Exp; 1968 Sep; 10(9):457-60. PubMed ID: 4386689
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparison of the clinical effect of short-term administration of Pondex, methylphenidate, and placebos in neuroses].
    Bojanovský J; Hánysová Z; Bouchal M; Náhunek K; Vanýsek J
    Act Nerv Super (Praha); 1967 Nov; 9(4):373. PubMed ID: 4388629
    [No Abstract]   [Full Text] [Related]  

  • 5. [Determination of the effect of the short-term administration of Pondex, methylphenidate, and placebo by various pshychological tests].
    Sindelárová M; Bojanovský J
    Act Nerv Super (Praha); 1967 Nov; 9(4):374. PubMed ID: 4388630
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of dantromin in geriatrics].
    Adamska-Dyniewska H
    Pol Tyg Lek; 1967 Apr; 22(17):641-3. PubMed ID: 4384172
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparison of Pondex, methylphenidate and placebo during short term administration and the effect on serum potassium, calcium and sodium levels in neurotic patients].
    Bojanovský J; Hánysová Z
    Act Nerv Super (Praha); 1967 Nov; 9(4):375-6. PubMed ID: 4388631
    [No Abstract]   [Full Text] [Related]  

  • 8. A new anti-fatigue agent in general practice.
    Meadley RG
    Practitioner; 1965 Nov; 195(169):680-3. PubMed ID: 4378985
    [No Abstract]   [Full Text] [Related]  

  • 9. Magnesium pemoline and job performance in mentally handicapped workers.
    Greenblatt DJ; DiMascio A; Messier M; Stotsky B
    Clin Pharmacol Ther; 1969; 10(4):530-3. PubMed ID: 4389444
    [No Abstract]   [Full Text] [Related]  

  • 10. [Value of "LB-125" in the treatment of emotional and behavior disorders in young children].
    Combes-Hamelle A; Stelian Y
    Therapeutique; 1970; 46(6):665-6. PubMed ID: 4393695
    [No Abstract]   [Full Text] [Related]  

  • 11. Influences of cylert upon memory changes with ECT.
    Small IF; Sharpley P; Small JG
    Am J Psychiatry; 1968 Dec; 125(6):837-40. PubMed ID: 4386991
    [No Abstract]   [Full Text] [Related]  

  • 12. Symposium: behavior modification by drugs. II. Psychological effects of stimulant drugs in children with minimal brain dysfunction.
    Conners CK
    Pediatrics; 1972 May; 49(5):702-8. PubMed ID: 4402496
    [No Abstract]   [Full Text] [Related]  

  • 13. Photic responses in "minimal brain dysfunction".
    Milstein V; Small JG
    Dis Nerv Syst; 1974 Aug; 35(8):355-7. PubMed ID: 17894071
    [No Abstract]   [Full Text] [Related]  

  • 14. Effectiveness of attention-deficit/hyperactivity treatment and diagnosis methods tested.
    Rep Med Guidel Outcomes Res; 2000 Feb; 11(4):1-2, 5-7. PubMed ID: 11768409
    [No Abstract]   [Full Text] [Related]  

  • 15. Psychosocial treatments for attention-deficit/hyperactivity disorder in children.
    Barkley RA
    J Clin Psychiatry; 2002; 63 Suppl 12():36-43. PubMed ID: 12562060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What's to be done with "bad" children?
    Nelson R
    Iowa Med; 1996; 86(9):373. PubMed ID: 8961633
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects and side effect in the treatment of children with stimulants (author's transl)].
    Klicpera C
    Fortschr Neurol Psychiatr Grenzgeb; 1978 Jul; 46(7):392-414. PubMed ID: 27439
    [No Abstract]   [Full Text] [Related]  

  • 18. Pemoline (Cylert): market withdrawal.
    Hogan V
    CMAJ; 2000 Jan; 162(1):106, 110. PubMed ID: 11216184
    [No Abstract]   [Full Text] [Related]  

  • 19. Pemoline augmentation for resistant depression.
    Benazzi F
    J Psychiatry Neurosci; 1997 Jan; 22(1):71. PubMed ID: 9002395
    [No Abstract]   [Full Text] [Related]  

  • 20. Observations about the use of psychopharmaca in child psychiatry.
    van Krevelen DA
    Acta Paedopsychiatr; 1971; 38(2):47-59. PubMed ID: 4399609
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.